RE:RE:RE:THRMADMIN..Looks like management is seeing that clinical trials is going to take much longer. Then getting approval even longer . So now they are like DM and others selling othets tests. Works ok if its a good test and can sell for a decent margin. But india and brazil already have many tests at cheap prices. VST with the test they bought iS not helping the share price. even with Brazil health (ANIVISA) and FDA approval.
terr2 wrote:
They don't have anything legally to distribute. They are patiently waiting for approvals from the different controlling bodies. Until such time that they can market the products , the share price will be slowly walked down into the dirty thirties. JMO